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Abstract
Background: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Filariasis relies on
mass drug administration (MDA) of two drugs annually for 4 to 6 years. The goal is to reduce the reservoir of
microfilariae in the blood to a level insufficient to maintain transmission by the mosquito vector. In 2008, the
international medical aid organization Médecins Sans Frontières (MSF) performed the first round of a MDA in the
high-burden area of Asmat district, in Papua, Indonesia. We report the challenges faced in this MDA on a remote
Indonesian island and propose solutions to overcome these hurdles in similar future contexts.
Results: During the MDA, we encountered difficult challenges in accessing as well as persuading the patient
population to take the antifilarial drugs. Health promotion activities supporting treatment need to be adapted and
repetitive, with adequate time and resources allocated for accessing and communicating with local, seminomadic
populations. Distribution of bednets resulted in an increase in MDA coverage, but it was still below the 80-85%
target.
Conclusions: MDA for lymphatic filariasis is how the WHO has planned to eliminate the disease from endemic
areas. Our programmatic experience will hopefully help inform future campaign planning in difficult-to-access,
high-burden areas of the world to achieve target MDA coverage for elimination of lymphatic filariasis.
Background
Lymphatic filariasis (LF) is a parasitic disease trans-
mitted by mosquito bites which causes disability and
adversely impacts the economy of the developing coun-
tries where it is endemic. LF is the fourth most common
cause of disability worldwide [1]. It is caused by
Wuchereria bancrofti, Brugia malayi,o rBrugia timori.
These parasites reside in lymphatic channels or lymph
nodes where they remain viable for more than two dec-
ades. W. bancrofti is the most widely distributed, affect-
ing an estimated 115 million people throughout the
tropics and subtropics. The World Health Organization
(WHO) estimates that 120 million people are currently
infected and more than 1 billion people are at risk in 83
countries [1]. Approximately 40 million people are ser-
iously incapacitated and disfigured by the disease [1,2].
LF disease transmission can be stopped through a fea-
sible, effective, and relatively inexpensive prevention
strategy through mass drug administration (MDA) of
two oral drugs to at-risk populations once a year [3-5].
These drugs kill the microfilariae in an infected patient’s
blood so that mosquitoes cannot transmit the disease to
others. This MDA-based strategy of transmission inter-
ruption is part of the WHO’s Global Program to Elimi-
nate Lymphatic Filariasis [6].
Filariasis is an eradicable disease of high prevalence
among several of the islands of Indonesia. Due to the
high prevalence and remote distribution and diversity of
filarial infections, filariasis elimination in Indonesia is a
major challenge [7].
In 2008, the international medical aid organization
Médecins Sans Frontières (MSF) offered to carry out the
first round of a MDA in the district of Asmat, Papua,
Indonesia, where LF was found to be endemic. We
report here our experience and the challenges faced in
this MDA against LF in Asmat over an 11-week period
from July to September 2008.
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Outcomes of the MDA Campaign
The first MSF filariasis campaign took place in Asmat
District from July 9, 2008, the date of the first MDA
activity, to September 22, 2008, date of the last MDA
activity. All the 7 subdistricts were covered, comprising
147 villages visited over 28,000 km
2.
A total of 36,478 people took the drug treatment, giv-
ing an average coverage of 58% of the targeted popula-
tion. The teams spent a total of about 1,000 hours on
boats, consuming a total of 24 tons of fuel, representing
an average of 1.5 people treated per liter of fuel used in
this campaign.
Program Challenges
Accessing and communicating with populations and
workers
Because of their remoteness, the villages were not often
v i s i t e db yo u t s i d e r sa n dw e r ea c c e s s i b l eo n l yb yb o a t .N o
radio, television, or newspaper media exist, ruling out
advertising educational campaigns through the mass
media. Due to this difficulty of accessing local popula-
tions, villagers were visited by local health workers about
once a month. Workers went to the villages a few weeks
before the MDA campaign, and the upcoming campaign
was mentioned. Attempts were sometimes made to send
out dates of the MDA through the District Health Office
(DHO), but these notices were often not distributed.
Local health workers however did not perform much
health promotion, with most of this task handled by
MSF. For example, some puskesmas (local health center)
staff did not receive invitations for training since postal
service is nonexistent in the villages of Asmat, though
radio communication to the puskesmas was present at
times. Messages were often conveyed word-of-mouth
a n dd e p e n d e do nt h en e x tb o a tt h a ta r r i v e df r o mA g a t ,
the capital.
In the village of Yahoi in Fayit, there had been some
deaths from snakebites the previous 2 years, and the vil-
lages asked for antivenom. Later, on the day of MDA,
some villagers were agitated that MSF was treating filar-
iasis in people who had no obvious signs of the disease,
when they needed basic health care for diseases like
malaria and diarrhea. The physician happened to be
there to explain to the people that filariasis can be eradi-
cated with these drugs, but means to eradicate malaria
and diarrhea, for instance, have not been found yet.
MSF faced program difficulties in Sawa Erma, the sub-
district with the largest population. Rumors in the sub-
district included, “you drown if you take the drugs” and
“someone died in Agat after taking the drugs.” With the
vastness of this subdistrict (Sawa Erma) and a little
under 2 weeks allotted to it, we experienced a marked
fall in drug administration compliance, averaging only
37% population coverage. Convincing the local popula-
tion was difficult, as they had little trust in the MDA
program. To try to remedy this, the village chief in Sawa
took the drugs to demonstrate their safety (a practice
often repeated throughout the campaign), but the people
watching still would not register to take the drugs. Talk-
ing to reassure them was also not helpful. This difficulty
was not encountered in other subdistricts.
In other subdistricts, for instance in Atsy and Pantai
Kasuari, where there was insufficient health care, people
came to us and requested health care. Some people nar-
rated the number of infant deaths from diarrhea in the
previous year, or the high number of asthma cases in a
village. When we explained that we were just working
on filariasis in collaboration with the DHO, it was hard
to gain trust. The population, rightly, had concerns
about other diseases that were life-threatening. In the
face of health care difficulties such as these, just telling
the needy villagers we would pass the word along, and
that our task here was only MDA, may have sounded
superficial. This has been the experience in other MDA
campaigns as well [8].
The village headmen were often absent, so finding a
person the villagers trusted, who would help convince
them, was also a challenge. Villagers were sometimes
absent from villages, lowering coverage. The reasons
given were “they have gone to Agat” or “they are in the
forest looking for food.” Visits to bewaks (temporary
river shelters) were not always fruitful since people were
in the forest.
Population numbers were often unreliable. The num-
bers provided by the DHO were projections from the
2000 census when Asmat was still part of the district of
Merauke. No newer numbers were available at the time
of the intervention. These numbers were found to be
inflated when one talked to village authorities and tallied
numbers. For instance, in the village of Yomoth, our
population figure was 647, the village head told us 502,
and a village elder told us only about 300 people actu-
ally lived in the village. A total of 180 people were trea-
ted with the drugs. Drug coverage could not therefore
be accurately determined.
One or two hours of health promotion, depending on
village size, was not always sufficient to convince people
of the importance of taking the drugs. Establishing trust
took more time and effort than anticipated.
Mapping of bewaks
No maps were available indicating each village’s bewaks,
probably because they are temporary structures. But
accessing people living in bewaks was crucial to the suc-
cess of a campaign of this nature, which necessitates
high coverage. Knowing the locations of bewaks was
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Erma. Information on bewaks was not available, nor
attempted to be obtained, at the time of MDA planning.
Exploration was not done in this subdistrict since
mobile clinics had been conducted here, but the popula-
tions who came for mobile clinics had sought medical
attention for other ailments.
The bewaks tended to be scattered and only villagers
could take us to them, something not factored into the
time frame of the campaign. In the time table for the
campaign, one day was allotted for each village of a sub-
district. To return to base by 5:00 PM, a team may
sometimes have to leave 2 hours beforehand, and that
left no time to visit a large portion of the populations in
bewaks. Also, bewaks were often inaccessible even when
there was time to visit them for drug distribution.
Treatment incentives
Population turnout and compliance was best in the 4 sub-
districts where bednets were distributed (Table 1). People
often rowed long distances from bewaks and even came to
our base village to take drugs when these people had been
absent at the time of drug distribution in villages.
Staying overnight in villages after drug distribution so
adverse events could be examined and treated helped
increase compliance. The adverse events noted were
fever, nausea, and vomiting. When the team could stay
on a little later after the end of drug distribution (being
close to or in the base village), people’sq u e s t i o n sw e r e
answered, and adverse events could be ascertained and
treated appropriately.
Discussion
Lessons Learned
Lessons learned to potentially apply to future MDA
campaigns include:
1. In remote locations with no media presence and
with the difficulty of transportation to remote vil-
lages and their bewaks, accurate mapping must be
carried out first.
2. Adequate time must be allocated for studying the
populations and devising effective health promotion
techniques in collaboration with local health authori-
ties and respected figures in the area. Such feedback
is crucial. Visiting villages at least once before the
start of the campaign to introduce it, meeting with
village elders and establishing rapport, and returning
to repeat and announce the campaign date may be
effective strategies.
3. Adequate time must be allotted to the actual
MDA campaign so that (a) geographically most if
not all the population can be reached; (b) villages
can be revisited, if possible, to allow time for people
to come from places such as bewaks; (c) lessons
learned from villages covered early on in the cam-
paign can be applied meaningfully to villages visited
later; and (d) unforeseen events such as inappropri-
ate weather or fuel shortages can be dealt with
easily.
4. Incentives to the LF-affected populations may be
useful in improving compliance. These can be mate-
rials (eg, bednets) or human resources (eg, holding
free clinics to treat other ailments if time permits).
5. Polyvalent teams are more efficient (for both
health promotion and MDA activities):
￿ The same team should do health promotion
and MDA activities in one village
￿ Optimal team is composed of one nurse, one
health promoter, and one logistician
￿ About 1.5 hours needed for health promotion
activity in one village.
Table 1 Population coverage of filariasis MDA in 7 subdistricts of Asmat district, Papua, Indonesia, 2008
Subdistrict Total population* Target population
† MDA coverage,*n (%) Bednets used
Agats
‡ 8349 6679 5207 (78.0) 0
Akat 6465 5172 2964 (57.3) 0
Sawa Erma 15,204 12,169 4263 (35.0) 0
Suator 8139 6511 3958 (60.8) 1404
Atsy 14,867 11,894 7730 (65.0) 2444
Fayit 6939 5551 4085 (73.6) 1295
Pantai Kasuari 16,147 12,918 7751 (60.0) 2400
TOTAL 76,110 60,893 35,958 (59.1) 7543
MDA, mass drug administration
*Only villages originally planned for MDA coverage and reached were included in this analysis.
†Target population calculated as 80% of total population.
‡In Agats subdistrict, the village of Bis Agats received multiple sweeping rounds (since it was near MSF headquarters and thus most accessible) and numerous
visitors from neighboring villages, resulting in very high coverage (157%) that could possibly skew the overall coverage picture of Agats. If Bis Agats is excluded,
then total population = 5758, target population = 4606, coverage n = 1952, and % coverage = 42.4%.
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mately 60 patients/hour (suitable for a village),
up to 500 people/day
6. Local people within the staff can help reassure the
populations during MDA
Strategies for Accessing Hard-to-Reach Populations
Reaching the seminomadic populations in Asmat for LF
MDA was a challenge, as was convincing people to take
the drugs. Coupled with remoteness of location, and no
readily utilizable mass media, an effective MDA requires
sufficient time, repeat visits, and high emphasis on
health promotion and establishing trust with local popu-
lations. Eliciting direct help and guidance from local,
respected, high-standing villagers and sometimes mis-
sionaries and local pastors can be useful. Taking the
necessary time and effort to establish understanding and
trust should be borne out in future MDA campaigns.
Coupled incentives to populations, such as distributing
bednets, may help increase compliance.
Conclusions
Preventative MDA for a disease such as filariasis, which
is chronic and has seemingly little effect on day-to-day
life, is a major challenge. Filariasis affects parts of the
w o r l dt h a ta r en o ti n d u s t r i a l i z e da n dw h e r ep e o p l em a y
not be generally aware of disease risk. Since MDA is
done among the general population, the majority of
whom have no symptoms of filariasis, compliance is the
major hurdle. In this experience, when bednets were
given with the drugs, compliance increased, indicating
the potential importance of such incentives to popula-
tions when a non-life-threatening disease such as filaria-
sis is targeted for intervention.
Methods
Intervention Setting and Characteristics
Papua is the second largest island in the world and is
governed by two countries: Papua New Guinea in the
east and Indonesia in the west. The district of Asmat in
western Papua has an area of about 28,000 km
2 and
population of over 75,000. Asmat district has 7 subdis-
t r i c t s :A g a t s ,A k a t ,S a w aE r m a ,S u a t o r ,A t s y ,F a y i t ,a n d
Pantai Kasuari.
MSF provided mobile clinics in Agats, Akat, and Sawa
Erma from 2006 to 2008. MSF staff were based in Agat,
the center of Agats and the capital of Asmat, and in the
village of Pos in Sawa Erma (Figure 1). The MDA was
carried out in the following order: Agats to Akat to
Sawa Erma, and then Atsy, Suator, Fayit, and Pantai
Kasuari.
Off the Arafura Sea, Asmat district is remote, with
access to villages only by boat via rivers that jut inland.
The area is mainly swamp land and lacks electricity,
roads, agriculture, and other modern facilities. The
population is relatively poor and primarily has a middle-
school level of education, with men tending to be edu-
cated at a higher level than the women. Fishing and
foraging for wood for trade are the main occupations.
The village population is divided between the actual
village, and bewaks, temporary shelters built on rivers
where groups of villagers go for a few months each year
to forage in the forest for food and wood (Figure 2).
Bewaks belong to particular villages. Families travel in
kolekole, which are dug-out, narrow, long wooden
canoes typically rowed by two people (Figure 3).
Local health care is offered in the form of health cen-
ters called puskesmas, with one each in a subdistrict
capital, and village health posts called pustus, run by a
nurse and/or midwife. The DHO (also known as Dinas
Kesehatan) is based in Agat, the district capital.
Beginning in November 2006 over 2 years, MSF
helped provide basic health care through mobile clinics.
In February 2008, MSF launched a study comparing the
performance of three malaria rapid diagnostic tests with
that of microscopy (gold standard). A total of 492
patients were included in this study from 3 subdistricts
(Sawa Erma, Agats, and Akat) in which 245 (49.8%)
were children under 5 years of age. Most of the patients
came from Sawa Erma (60.2%). Microfilariae were found
among 10 patients: 6 positive for W. bancrofti, 2 positive
of B. malayi, and 2 mixed between W. bancrofti and B.
malayi. All were from Sawa Erma subdistrict in 5 vil-
lages (Bu Agani, Aou, Kappi, Weo, and Mumugu),
which confirmed the clinical findings. The microfilaria
rate was thus 2.03%, which exceeds the criteria of the
Ministry of Health (MOH) and WHO (≥1%) to declare
an area as endemic [9].
In Asmat, both limb elephantiasis and hydrocele
(enlargement of the scrotum with fluid due to obstruc-
t i o no fl y m p h a t i cd r a i n a g eb yt h ew o r m )a r es y m p t o -
matic manifestations of chronic filariasis. Occasionally,
unilateral breast enlargement has also been observed.
Because the district did not have the required budget
to carry out a MDA campaign for filariasis, in 2008
MSF offered to perform the first round of MDA. The
MOH and DHO committed to continuing the campaign
f o rt h er e m a i n i n gf o u rr o u n d so v e rt h ef o l l o w i n g
4 years.
Medical and Health Promotion Teams and Strategy
The filariasis MDA team was comprised of one field
coordinator, one physician (medical coordinator),
4 nurses, and 8 health promoters, in addition to the
logistics staff (Figure 4). The medical teams were com-
prised of one nurse, one health promoter, a logistician,
and a boat driver. The health promotion teams each
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Figure 2 Bewak. Credit: Navneet Bhullar/MSF. Figure 3 Kolekole. Credit: Navneet Bhullar/MSF.
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plete MDA team of initially 27 people was expanded to
29 to cover the last 2 subdistricts.
The health promotion team traveled to villages and
spoke with the village chief or another respected person.
They then gathered the villagers at a common place and
introduced themselves, and described filariasis and the
importance of eradicating it. The team explained that all
villagers (except pregnant and lactating women, persons
with ongoing fever, and the chronically ill) would be
given three drugs for this purpose, two to treat the
active and nascent disease (albendazole and diethylcar-
bamazine) and the third (paracetamol) to reduce side
effects. The team used flip charts and leaflets as educa-
tional aids, and hung posters explaining the disease
cycle and drugs in simple terms. In subdistricts where
MSF had not worked before, MSF newsletters were
given to the village chief.
Written materials were in Bahasa Indonesia, the
national language of Indonesia. The team used micro-
phones to walk around the village announcing the day
of the MDA campaign, along with the venue advised by
the village elders. The team met with midwives and/or
kaders (community health workers) to help with
registrations.
One to three days after the health promotion team
visited a village (except in the largest subdistrict of Sawa
Erma, where longer time sometimes elapsed between
health promotion and MDA activities), the MDA team
arrived in the morning, set up base at the decided
venue, briefly described the disease and treatment again,
and proceeded to start MDA. When turnout was low,
the team sometimes went door to door. Also, in such
cases, they went to the bewaks close by, if accessible.
The team was required to leave at a time that would
allow them to return to the team base by 5:00 PM
(since the boats did not have adequate equipment for
navigation in the dark). The base was the central village
where all the teams stayed while MDA was done in one
subdistrict.
At the end of each subdistrict, sweeping (the process
of returning to a population with drugs where adequate
coverage was not accomplished the first time) was done
in 4 villages with the least coverage on the original
MDA day. As an ancillary to the MDA, registration of
hydrocele in men and malnutrition in children 2-5 years
Figure 4 Filariasis MDA team organizational chart, Asmat district, Papua, Indonesia, 2008. MDA, mass drug administration; HP, health
promotion.
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cele repair was to be planned. This was done a few
months after the end of the MDA campaign.
In the subdistricts of Atsy, Suator, Fayit, and Pantai
Kasuari, one bednet was given to each family adminis-
tered drugs. Villagers were informed of this distribution
on the day of health promotion, and it was made clear
that bednets were not a cure for filariasis, but helped
prevent malaria and could help with filariasis prevention
to some degree as well. The bednets had already been
distributed for malaria prevention in the other subdis-
tricts over the last 2 years since MSF had had a pre-
sence there.
Health Worker Training
Conducted by MSF, this first round of the MDA campaign
was a collaboration with the DHO. Two doctors from the
MOH arrived from Jakarta to help in the training of local
health and MSF staff. Doctors from the 7 puskesmas of
Asmat were invited, as were some ancillary health staff.
The training lasted one day and covered:
￿ History of MSF in the area and our past activities
￿ H o wM S Fd e c i d e dt oc a r r yo u tt h ef i r s tr o u n do f
MDA
￿ MOH policy for implementing the filariasis
program
￿ Pathophysiology, symptoms, diagnosis, complica-
tions, prevention, and treatment of filariasis in the
international context
￿ Filariasis in Asmat
￿ Health promotion strategies
￿ MDA organization at health center level
￿ Demonstration of drug distribution and MDA
technique
￿ Adverse reactions of drugs (minimal and minor)
￿ Methods of reporting drug administration coverage
￿ Security guidelines
Health promotion training involved educating the
patient populations of the ancillary effects of the filaria-
sis drugs, such as the elimination of intestinal helminths
and decreases in infant and maternal morbidity. Train-
ing of MSF staff was reinforced after 5 subdistricts were
completed. Training was also improvised as we encoun-
tered patients who complained of limb pain, fever, and
itching after drug treatment. The patients were told, for
instance, that if adverse events were encountered, it
meant the drugs were working (so they would not
assume the drugs were making them sick and pass that
on to other villagers), and to seek treatment for adverse
events in the local health centers.
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